Abstract
A number of studies have indicated that 8p22–p12 is likely to harbor schizophrenia susceptibility loci. In this region, the candidate gene of interest, neuregulin 1 (NRG1), may play a role in the pathogenesis of schizophrenia. Then in the present study, we performed the linkage disequilibrium to determine the association between three genetic variants (SNPs: rs3924999, rs2954041, SNP8NRG221533) on NRG1 gene and schizophrenia in 246 Chinese Han schizophrenic family trios using PCR-based restriction fragment length polymorphism method and denaturing high-performance liquid chromatography. The transmission disequilibrium test analysis for each variant showed a significant difference between two transmitted alleles even after Bonferroni correction (rs3924999, P=0.007752; rs2954041, P=0.0009309; SNP8NRG221533, P=0.012606). The global χ2 test for haplotype transmission also revealed a strong association (χ2=46.068, df=7, P<0.000001). Our results suggest that the NRG1 gene may play a role in conferring susceptibility to the disease.
Main
Schizophrenia is a complex disease, a common mental disorder with a prevalence of 0.5–1% in the general population. It is clinically characterized by disturbed thought processes, delusions, hallucinations, and/or reduced social skills.1 A number of studies indicate a genetic component contributing to schizophrenia, but the mode of inheritance does not follow a simple Mendelian pattern. In spite of the failure to identify a schizophrenia gene of major import in multiply affected families, more than one data set from genome-wide scans provides convincing evidence that 8p22–p21 may harbor candidate genes which may confer susceptibility to schizophrenia to an individual.2,3,4,5 Interestingly, two studies carried out by Stefansson et al6,7 reported that the gene coding for neuregulin 1 (NRG1) was located in 8p21; its position as well as function strongly supported NRG1 gene as a susceptibility gene for schizophrenia. In their study, however, they had not found a clear pathogenic mutation. Several dozens of single nucleotide polymorphisms (SNPs) have been identified within the locus (http://www.ncbi.nlm.nih.gov/SNP/), of which we randomly selected two that can be detected by the restriction fragment length polymorphism (RFLP) analysis. Of the two SNPs, one SNP (rs3924999, G38A), a G to A base change, occurs in position 12 within the second exon of the NRG1 gene, and the database (http://www.ncbi.nlm.nih.gov/SNP/) shows that the SNP changes the amino acid from arginine (Arg) to glutamine (Gln) (Arg 38 Gln). Another SNP (rs2954041), located in fifth intron, may still be informative, for example, by being in linkage disequilibrium with a causal locus for schizophrenia. Therefore, it is valuable to investigate the possibility that these polymorphism sites on the NRG1 locus may be associated with schizophrenia. We also genotyped the single most significant SNP (SNP8NRG221533) described in Stefansson's findings6,7 by denaturing high-performance liquid chromatography (dHPLC) in order to clarify the similarities or differences of SNP8NRG221533 polymorphism in the different populations.
In the present study, we conducted association analysis to determine the relationship between NRG1 gene and schizophrenia. As the transmission disequilibrium test (TDT), which evaluates allele transmissions from heterozygous parents to affected individuals, provides an index of association which is unbiased by population structure. Therefore, we performed a family-based test in the present study.
We analyzed the three polymorphisms of NRG1 gene in 246 Chinese Han schizophrenic family trios by the PCR-based RFLP and dHPLC. The genotype distributions and allelic frequencies are presented in Table 1. The TDT analysis for each locus showed a significant difference between two transmitted alleles (Table 2) even after Bonferroni correction (rs3924999, P= 0.007752; rs2954041, P=0.0009309; SNP8NRG221533, P=0.012606). As haplotype has more accuracy and statistical power than individual SNPs in linkage-disequilibrium-based association study, we estimated haplotype frequencies of the three SNPs with TRANSMIT software.8 The global χ2 test for haplotype transmission also revealed a strong association between the NRG1 locus and schizophrenia (χ2=46.068, df=7, P<0.000001). As shown in Table 3, the 1-df test for individual haplotypes demonstrated that an excess of the TAG haplotype was transmitted by the parent to the affected offspring (χ2=17.134, df=1, P<0.000035).
NRG1 is one family member of structurally related glycoproteins that include NRG2, NRG3, and NRG4.9 NRG1 plays a role as a multifunctional factor in the neurodevelopment and many aspects such as cell differentiation. In mouse embryos of 14.5 days, Orr-Urtreger et al10 found that NRG1 expression was confined predominantly to the central and peripheral nervous systems, including the neuroepithelium lining the lateral ventricles of the brain, the ventral horn of the spinal cord, and the intestinal as well as dorsal root ganglia. Through a ribozyme-based strategy for the perturbation of NRG1 function in developing chick embryos, Zhao and Lemke11 discovered that NRG1 could promote both muscle cell differentiation in the heart and neuronal differentiation in the central nervous system. Recently, Huang et al12 reported that neuregulins and their receptors, the ERBB protein tyrosine kinases, are essential for neuronal development and involved in long-term potentiation in the hippocampal CA1 region without affecting basal synaptic transmission, the brain mechanisms considered important for memory formation, and they also considered that the signaling role of NRG in the central nervous system of adults may be involved in the modulation of synaptic plasticity.
In Stefansson et al's study,6,7 they found that a core at-risk haplotype represented a block of linkage disequilibrium containing the 5′exon of NRG1 and upstream; however, the only SNP (SNP8NRG433E1006) in the exon of NRG1 was not found in significant excess in patients. In the present study, we conducted an association analysis to examine the relationship between the NRG1 locus and schizophrenia in a Chinese population. Both the TDT and the haplotype analysis showed a strong association between the NRG1 locus and schizophrenia. In our sample, the SNP8NRG221533, which gave the best single marker association in the study of Stefansson et al showed significant evidence, although its significance was less statistically than the other two polymorphisms. These results not only confirmed the finding reported by Stefansson et al, but also extended the linked haplotype block from the 5′exon of NRG1 to the fifth intron in Chinese Han people. In the haplotype block, the SNP rs3924999 is located in the second exon of the NRG1 gene (nucleotide sequence site 1200844), which is conservative in all isoforms of NRG1, and the database (http://www.ncbi.nlm.nih.gov/SNP/) shows that this SNP is a functional polymorphism (Arg 38 Gln). However, to examine whether the SNP is a clear pathogenic mutation in the protein level would be required. The other SNP rs2954041 also showed the linkage disequilibrium. Located in the fifth intron, the result suggested that this site might be linked with functional loci, either SNP rs3924999 or other loci. Thus, we could not exclude the other linkage polymorphic sites in NRG1 gene such as enhancers or other controlling sites.
In summary, our results, along with Stefansson's findings, suggested that the NRG1 gene might either play a role in predisposing an individual to schizophrenia or be in linkage disequilibrium with a causal locus for schizophrenia. Therefore, it is necessary to carry out further investigation to confirm these findings by replicating studies as well as genotyping haplotypes within the NRG1 and adjacent loci.
Materials and methods
Subjects
Schizophrenic patients and their biological parents were recruited for the present study at the Institute of Mental Health, Peking University, China. All the subjects were Chinese of Han descent. All patients met the ICD-10 criteria. Of the patients, 138 (56%) were male and 108 (44%) female, mean age 29 years. The mean duration of illness was 5 years. All subjects gave informed consent for genetic analysis. The study was approved by the Ethics Committee of Peking University.
Peripheral blood samples were obtained from subjects and genomic DNA was extracted using the phenol–chloroform method.
Genotyping
PCR-RFLP
Two SNPs (rs3924999, rs2954041) were genotyped by the PCR-based RFLP analysis for all subjects. Primers and restriction enzymes used are described in Table 4. PCR amplification was performed in 25-μl reaction volume containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.001% (w/v) gelatin, 200 μM of each dNTP, 0.4 μM of each primer, 1.0 U of Taq DNA polymerase, and 40 ng genomic DNA. The conditions used for PCR amplification included an initial denaturation at 94°C for 5 min, followed by 35 cycles at 94°C for 30 s, 55–62°C for 40 s, 72°C for 1 min, and a final elongation at 72°C for 10 min. A 15-μl aliquot of the PCR product mixtures was completely digested with 5 U of restriction enzyme and then separated on 4% (SNP1) and 5% (SNP2) agarose gels.
dHPLC
The DNA sequence containing the SNP8 NRG221533 was amplified with a pair of primers: 5′ GCA TTA GAA CTA GAA CTT GCG TGA 3′ and 5′ TGG GAA CTC TCC ATC TCT TTC A 3′. Before dHPLC analysis, PCR products were denatured by heating to 94°C for 1 min, and were then allowed to reanneal by cooling to 50°C over 25 min.
dHPLC. was performed using a WAVE DNA fragment analyzer (Transgenomic). Column temperature for dHPLC analysis was determined using software that is available free of charge over the Internet (http://insertion.standford.edu/melt.html).13 To ensure maximum sensitivity, in addition to the temperature suggested by the software (n°C), each fragment was also run at n±2°C. Where dHPLC analysis suggested that a subject was heterozygous, the PCR products from that individual were sequenced to determine the nature of the polymorphism using the Big Dye Terminator Cycle Sequencing Kit (Perkin-Elmer Applied Biosystems) as described by the manufacturer.
Statistical analysis
The TDT14 was applied to analyze allelic association in family trios consisting of father, mother, and affected offspring with schizophrenia, where preferential allelic transmission from heterozygous parents to affected offspring is tested by applying the (b−c)2/(b+c) statistics and the χ2 (McNemar's test). The null hypothesis of no association indicates that each allele carried by a heterozygous parent has a 50% chance for transmission to an affected child. If the allele plays a causal role in the development of the disorder, then its transmission should exceed 50%. Haplotype frequency was estimated by TRANSMIT program, version 2.5.2.8 We applied Bonferroni corrections for all multiple statistical tests.
References
- 1.
Andreasen NC. Symptoms, signs, and diagnosis of schizophrenia. Lancet 1995; 346: 477–481.
- 2.
Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F et al. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiatry 1996; 153: 1534–1540.
- 3.
Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin JL et al. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am J Med Genet 1995; 60: 252–260.
- 4.
Schizophrenia Linkage Group. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for chromosomes 3, 6 and 8. Am J Med Genet 1996; 67: 580–594.
- 5.
Pulver AE, Mulle J, Swartz KL, Blouin J-L, Dombroski B, Liang K-Y et al. Genetic heterogeneity in schizophrenia: stratification of genome scan data using co-segregating related phenotypes. Mol Psychiatry 2000; 5: 650–653.
- 6.
Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 23,71: 877–892.
- 7.
Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72: 83–87.
- 8.
Chiano MN, Clayton DG. Fine genetic mapping using haplotype analysis and the missing data problem. Ann Hum Genet 1998; 62: 55–60.
- 9.
Wolpowitz D, Mason TBA, Dietrich P, Mendelsohn M, Talmage DA, Role LW. Cysteine-rich domain isoforms of the neure → gulin-1 gene are required for maintenance of peripheral synapses. Neuron 2000; 25: 79–91.
- 10.
Orr-Urtreger A, Trakhtenbrot L, Ben-Levy R, Wen D, Rechavi G, Lonai P et al. Neural expression and chromosomal mapping of NEU differentiation factor to 8p12-p21. Proc Natl Acad Sci USA 1993; 90: 1867–1871.
- 11.
Zhao JJ, Lemke G. Selective disruption of neuregulin-1 function in vertebrate embryos using ribozyme–tRNA transgenes. Development 1998; 125: 1899–1907.
- 12.
Huang YZ, Won S, Ali DW, Wang Q, Tanowitz M, Du QS et al. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000; 26: 443–455.
- 13.
Jones A, Austin J, Hansen N, Hoogendoorn B, Oefner PJ, Cheadle JP et al. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 1999; 45: 1133–1140.
- 14.
Spielman RS, McGinnis RE, Ewens WJ. Transmission tests for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–516.
Acknowledgements
We express our gratitude to all patients and their family members, without whose cooperation, this work would not have been possible. We also thank Professor Lian Zhang, Professor Kaifeng Pang in Beijing Institute for Cancer Research in helping us to carry out dHPLC. This work has been supported by Grant H010210180112 from Beijing Biomedical R & D Innovation Program, Grant 30000059 from the National Natural Scientific Foundation of China, Grant 2000-A-A32 from Peking University Center for Human Disease Genomics, and Grant 2002BA711A07-06 from National Key Project.
Author information
Author notes
- J Z Yang
- & T M Si
Contributed equally to this work.
Affiliations
Institute of Mental Health, Peking University, Beijing 100083, China
- J Z Yang
- , T M Si
- , Y Ruan
- , Y S Ling
- , Y H Han
- , X L Wang
- , M Zhou
- , H Y Zhang
- , Q M Kong
- , C Liu
- , D R Zhang
- , L Shu
- & D Zhang
The Center for Genomic Medicine, University of Jilin, Changchun 130021, China
- Y Q Yu
- , S Z Liu
- & G Z Ju
Peking University Center for Human Disease Genomics, Beijing 100083, China
- D L Ma
Authors
Search for J Z Yang in:
Search for T M Si in:
Search for Y Ruan in:
Search for Y S Ling in:
Search for Y H Han in:
Search for X L Wang in:
Search for M Zhou in:
Search for H Y Zhang in:
Search for Q M Kong in:
Search for C Liu in:
Search for D R Zhang in:
Search for Y Q Yu in:
Search for S Z Liu in:
Search for G Z Ju in:
Search for L Shu in:
Search for D L Ma in:
Search for D Zhang in:
Corresponding author
Correspondence to D Zhang.
Rights and permissions
To obtain permission to re-use content from this article visit RightsLink.